B

Bain Capital Life Sciences Investors, LLC

Bain Capital Life Sciences Investors, LLC is an institution, managing $1.5B across 20 long positions as of Q3 2025 with 69% Healthcare concentration, 93% concentrated in top 10 holdings, and 28% allocation to HTFL.

Portfolio Value
$1.5B
Positions
20
Top Holding
HTFL at 27.84%
Last Reported
Q3 2025

Top Holdings

Largest long holdings in Bain Capital Life Sciences Investors, LLC's portfolio (92.8% of total portfolio)

See all holdings
HoldingSectorPositionWeightTradedOwnership
Unknown
Unknown
$419.0M
27.84%
+$419.0M
New
14.93%
12.4M shares
Biotechnology
Healthcare
$304.9M
20.26%
9.52%
10.7M shares
Biotechnology
Healthcare
$289.3M
19.22%
+$49.8M
Bought
11.91%
3.0M shares
Biotechnology
Healthcare
$79.4M
5.27%
-$3.0M
Sold
4.95%
3.2M shares
Biotechnology
Healthcare
$67.0M
4.45%
9.97%
6.8M shares
6
Savara logo
Savara
SVRA
Biotechnology
Healthcare
$62.8M
4.18%
10.18%
17.6M shares
Biotechnology
Healthcare
$51.8M
3.44%
-$45.9M
Sold
3.30%
1.3M shares
Biotechnology
Healthcare
$48.8M
3.24%
10.16%
7.9M shares
Unknown
Unknown
$45.9M
3.05%
4.53%
2.4M shares
Medical - Devices
Healthcare
$28.2M
1.87%
19.08%
8.4M shares

Analytics

Portfolio insights and performance metrics for Bain Capital Life Sciences Investors, LLC

View analytics

Sector Allocation

Healthcare: 69.10%Healthcare
Healthcare
69.10%

Market Cap Distribution

Mid Cap ($2B - $10B): 67.32%Mid Cap ($2B - $10B)Small Cap ($300M - $2B): 26.21%Small Cap ($300M - $2B)Micro Cap ($50M - $300M): 5.92%Nano Cap (< $50M): 0.55%
Mid Cap ($2B - $10B)
67.32%
Small Cap ($300M - $2B)
26.21%
Micro Cap ($50M - $300M)
5.92%
Nano Cap (< $50M)
0.55%

Portfolio Concentration

No concentration data available

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.